The 11 currently reportable or actionable variants for non-small cell lung cancer (NSCLC) were extensively verified (n=126) (ALK, EGFR, BRAF, KRAS, NTRK 1/2/3, ROS, RET, MET, ERBB2). This evidence concerns the gene ALK and non-small cell lung carcinoma.